Whitehawk Therapeutics (WHWK) Other Non Operating Income (2016 - 2026)

Whitehawk Therapeutics (WHWK) has 8 years of Other Non Operating Income data on file, last reported at $1.3 million in Q1 2026.

• Other Non Operating Income for Q1 2026 came in at $1.3 million, down 98.49% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.8 million (down 97.97% YoY), and the FY2025 annual result was $302000.0, up 7650.0% from the prior year.
• Other Non Operating Income improved to $1.3 million in Q1 2026 per WHWK's latest filing, from $305000.0 in the prior quarter.
• Over five years, Other Non Operating Income peaked at $88.2 million in Q1 2025 and troughed at -$4.7 million in Q4 2023.
• A 5-year average of $6.3 million and a median of $562000.0 in 2022 frame the typical range for Other Non Operating Income.
• The sharpest annual moves came in 2023 and 2025: Other Non Operating Income slumped 317.9% in 2023, then soared 7725.0% in 2025.
• A 5-year view of Other Non Operating Income shows it stood at $2.2 million in 2022, then tumbled by 317.9% to -$4.7 million in 2023, then jumped by 99.92% to -$4000.0 in 2024, then soared by 7725.0% to $305000.0 in 2025, then surged by 335.41% to $1.3 million in 2026.
• Business Quant data shows WHWK's Other Non Operating Income at $1.3 million in Q1 2026, $305000.0 in Q4 2025, and $158000.0 in Q2 2025.